Allergan, Inc. (NYSE:AGN) today announced that its Board of Directors has approved, subject to stockholder approval, an amendment to Allergan’s restated Certificate of Incorporation that increases Allergan’s authorized number of shares of common stock from 300 million to 500 million.
